• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对呼吸道合胞病毒的人源和鼠源细胞毒性T细胞可识别痘苗病毒重组体表达的病毒核蛋白(N),而非主要糖蛋白(G)。

Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants.

作者信息

Bangham C R, Openshaw P J, Ball L A, King A M, Wertz G W, Askonas B A

出版信息

J Immunol. 1986 Dec 15;137(12):3973-7.

PMID:2431051
Abstract

The viral antigens recognized by cytotoxic T cells (CTL) have not been defined in most viruses infecting mouse or man. Natural or artificial virus recombinants can be used to determine the antigen specificity of CTL directed against viruses with segmented genomes, such as influenza, but this technique is more difficult to apply to the study of unsegmented viruses. We describe here the use of recombinant vaccinia viruses, containing cDNA corresponding to either the nucleoprotein (N) gene or the major surface glycoprotein (G) gene of human respiratory syncytial virus (RSV), to examine the antigen specificity of anti-RSV cytotoxic T cells from humans and mice. The results demonstrate that the RSV N protein is one of the target antigens for CTL in man and mouse, whereas the G protein was not recognized and can at best represent a minor target antigen for CTL.

摘要

在大多数感染小鼠或人类的病毒中,细胞毒性T细胞(CTL)识别的病毒抗原尚未明确。天然或人工病毒重组体可用于确定针对具有分段基因组的病毒(如流感病毒)的CTL的抗原特异性,但该技术更难应用于非分段病毒的研究。我们在此描述了使用重组痘苗病毒,其包含对应于人类呼吸道合胞病毒(RSV)核蛋白(N)基因或主要表面糖蛋白(G)基因的cDNA,来检测来自人类和小鼠的抗RSV细胞毒性T细胞的抗原特异性。结果表明,RSV N蛋白是人和小鼠中CTL的靶抗原之一,而G蛋白未被识别,充其量只能代表CTL的次要靶抗原。

相似文献

1
Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants.针对呼吸道合胞病毒的人源和鼠源细胞毒性T细胞可识别痘苗病毒重组体表达的病毒核蛋白(N),而非主要糖蛋白(G)。
J Immunol. 1986 Dec 15;137(12):3973-7.
2
Viral cross-reactivity and antigenic determinants recognized by human parainfluenza virus type 1-specific cytotoxic T-cells.1型人副流感病毒特异性细胞毒性T细胞识别的病毒交叉反应性和抗原决定簇
Virology. 1994 Mar;199(2):376-83. doi: 10.1006/viro.1994.1135.
3
Rotavirus-specific cytotoxic T lymphocytes recognize overlapping epitopes in the amino-terminal region of the VP7 glycoprotein.轮状病毒特异性细胞毒性T淋巴细胞识别VP7糖蛋白氨基末端区域的重叠表位。
Virology. 1999 May 10;257(2):424-37. doi: 10.1006/viro.1999.9646.
4
Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB/c mice sensitized to the attachment G protein.在对黏附G蛋白致敏的BALB/c小鼠中,亚细胞表达位点和疫苗接种途径会影响呼吸道合胞病毒攻击后的肺部嗜酸性粒细胞增多情况。
J Immunol. 1998 Sep 1;161(5):2473-80.
5
Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.细胞毒性T淋巴细胞识别与HLA - A2相关的流感病毒基质蛋白片段。
Nature. 1987;326(6116):881-2. doi: 10.1038/326881a0.
6
Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.编码呼吸道合胞病毒G蛋白的质粒DNA是一种很有前景的候选疫苗。
Virology. 2000 Mar 30;269(1):54-65. doi: 10.1006/viro.2000.0186.
7
Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.针对细胞蛋白中表达的单纯疱疹病毒特异性细胞毒性T淋巴细胞(CTL)表位的CTL应答的诱导与持续。
Virology. 1996 Aug 1;222(1):269-74. doi: 10.1006/viro.1996.0419.
8
Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.鉴定单纯疱疹病毒1型(HSV-1)糖蛋白gC为HSV-1特异性记忆性细胞毒性T淋巴细胞的免疫显性抗原。
J Immunol. 1985 Jul;135(1):575-82.
9
Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.重组呼吸道合胞病毒表达白细胞介素-4与初次感染后炎症加速和细胞毒性T淋巴细胞反应无功能有关,但在野生型病毒攻击后则不然。
J Virol. 2005 Aug;79(15):9515-26. doi: 10.1128/JVI.79.15.9515-9526.2005.
10
HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response.甲型H1和H2亚型流感病毒的HA2亚基可诱导产生具有保护性的交叉反应性细胞毒性T淋巴细胞应答。
J Immunol. 1988 Feb 15;140(4):1264-8.

引用本文的文献

1
Intranasal Vaccination with a Respiratory-Syncytial-Virus-Based Virus-like Particle Displaying the G Protein Conserved Region Induces Severe Weight Loss and Pathology upon Challenge with Wildtype Respiratory Syncytial Virus.鼻腔内接种展示 G 蛋白保守区的呼吸道合胞病毒样颗粒的疫苗,在受到野生型呼吸道合胞病毒攻击时会引起严重的体重减轻和病理变化。
Viruses. 2024 May 24;16(6):843. doi: 10.3390/v16060843.
2
All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?所有目光都聚焦在预融合稳定的F结构上,但我们是否忽略了呼吸道合胞病毒疫苗设计中替代靶点的潜力?
Vaccines (Basel). 2024 Jan 18;12(1):97. doi: 10.3390/vaccines12010097.
3
Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination.
单次剂量黏膜复制子-颗粒疫苗可预防尼帕病毒感染,在接种后 3 天内可有效抵抗致死性感染。
Sci Adv. 2023 Aug 4;9(31):eadh4057. doi: 10.1126/sciadv.adh4057.
4
New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus.呼吸道合胞病毒基于抗体疗法的新进展与挑战
Infect Drug Resist. 2023 Apr 8;16:2061-2074. doi: 10.2147/IDR.S379660. eCollection 2023.
5
Identification of a DRB3*011:01-restricted CD4 T cell response against bovine respiratory syncytial virus fusion protein.鉴定针对牛呼吸道合胞体病毒融合蛋白的 DRB3*011:01 限制性 CD4 T 细胞反应。
Front Immunol. 2023 Feb 20;14:1040075. doi: 10.3389/fimmu.2023.1040075. eCollection 2023.
6
The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses-Not Just Another Brick in the Viral Nucleocapsid.核蛋白在人体负链 RNA 病毒免疫中的作用——不只是病毒核衣壳的又一块砖。
Viruses. 2022 Mar 3;14(3):521. doi: 10.3390/v14030521.
7
Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?对儿童 COVID-19 发病率较低的反思:儿童免疫接种是否提供了意外的保护?
Med Hypotheses. 2020 Oct;143:109842. doi: 10.1016/j.mehy.2020.109842. Epub 2020 May 15.
8
New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.有助于开发有效疫苗和疗法以减少人呼吸道合胞病毒所致病理的新见解。
Int J Mol Sci. 2017 Aug 11;18(8):1753. doi: 10.3390/ijms18081753.
9
Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design.呼吸道合胞病毒所致肺炎的免疫学特征——对疫苗设计的启示
Int J Mol Sci. 2017 Mar 4;18(3):556. doi: 10.3390/ijms18030556.
10
Animal models of respiratory syncytial virus infection and disease.呼吸道合胞病毒感染与疾病的动物模型
Curr Opin Virol. 2015 Aug;13:117-22. doi: 10.1016/j.coviro.2015.06.003. Epub 2015 Jul 11.